Q-Line Biotech Balance Sheet Annual

BSE: - | NSE: QLINE | ISIN: INE1G2W01011 | Sector: Biotechnology & Drugs

651.10 -33.25 (-4.86%)Updated : 08 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Liabilities Shareholders' Equity	455.49	339.25	251.58	191.98
Accumulated Depreciation Total	-19.15	-12.56	-8.72	-1.30
Other Liabilities Total	3.99	2.06	1.76	0.00
Accrued Expenses	1.02	0.47	0.31	-
Long Term Debt	82.41	35.09	14.31	10.01
Common Stock Total	1.58	1.58	1.58	1.58
Other Current Assets Total	0.00	0.07	0.07	40.51
Prepaid Expenses	0.52	0.51	0.17	-
Total Assets	455.49	339.25	251.58	191.98
Current Portof LT Debt/ Capital Leases	28.42	11.42	5.17	-
Cash	47.03	29.96	90.02	46.54
Total Equity	189.95	161.81	127.37	102.00
Long Term Investments	42.39	46.21	29.51	-
Retained Earnings( Accumulated Deficit)	188.37	160.24	125.79	100.43
Total Common Shares Outstanding	2.33	2.33	2.33	2.33
Property/ Plant/ Equipment Total- Gross	131.66	86.60	43.19	10.70
Tangible Book Valueper Share Common Eq	71.27	67.20	54.56	43.72
Goodwill Net	0.27	0.00	0.00	-
Total Liabilities	265.54	177.43	124.21	89.97
Total Debt	166.29	96.91	73.65	43.43
Short Term Investments	0.00	0.00	0.00	7.57
Cashand Short Term Investments	47.03	29.96	90.02	54.11
Total Receivables Net	126.88	62.75	42.26	43.90
Notes Payable/ Short Term Debt	55.46	50.40	54.17	33.42
Deferred Income Tax	0.00	0.00	0.00	0.00
Accounts Receivable- Trade Net	82.60	26.44	33.06	43.03
Property/ Plant/ Equipment Total- Net	112.50	74.04	34.46	9.40
Total Current Liabilities	179.14	140.28	108.15	79.96
Total Inventory	90.21	105.24	43.59	37.63
Accounts Payable	55.62	59.24	39.71	34.66
Other Currentliabilities Total	38.62	18.75	8.79	11.88
Total Long Term Debt	82.41	35.09	14.31	10.01
Intangibles Net	23.42	5.05	0.08	-
Other Long Term Assets Total	10.68	6.53	1.41	0.15
Note Receivable- Long Term	1.58	8.89	10.00	6.28
period Length	0.00	0.00	0.00	0.00
Total Current Assets	264.64	198.53	176.11	176.15